What Percent Does Bristol-Myers Squibb Spend On R&D, 30%, 40%, Or 50%?

Bristol-Myers Squibb's (NYSE: BMY) R&D expenses were 36% of its total revenues in 2018. Total expenses were largely driven by cost of goods sold and research and development (R&D), which together accounted for three-fourths of the company's total expenditure in 2018...